17th Mar 2008 09:00
Alizyme PLC17 March 2008 For Immediate Release 17 March 2008 ALIZYME PLC TR - 1: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existingshares to which voting rights are attached: Alizyme plc 2. Reason for the notification: An acquisition or disposal of voting rightsAn event changing the breakdown of voting rights 3. Full name of person(s) subject to the notification obligation: Barclays PLC 4. Full name of shareholder(s) (if different from 3.) 5. Date of the transaction and date on which the threshold is crossed orreached: 11/03/2008 6. Date on which issuer notified: 12/03/2008 7. Threshold(s) that is/are crossed or reached: 5% to below notifiable % 8. Notified details: A: Voting rights attached to shares +------------+---------------------+------------------------------------------------------+|Class/type |Situation previous to|Resulting situation after the triggering transaction ||of shares |the Triggering | || |transaction | ||if possible +----------+----------+----------+---------------------+---------------------+|using the |Number of |Number of |Number of |Number of voting |% of voting rights ||ISIN CODE |Shares |Voting |shares |rights | || | |Rights +----------+----------+----------+----------+----------+| | | | |Direct |Indirect |Direct |Indirect |+------------+----------+----------+----------+----------+----------+----------+----------+|Ordinary |11,025,963|11,025,963|Not |Not |Not |Not |Not ||Shares | | |Reportable|Reportable|Reportable|Reportable|Reportable|| | | | | | | | ||GB0000374289| | | | | | | |+------------+----------+----------+----------+----------+----------+----------+----------+ B: Financial Instruments Resulting situation after the triggering transactionType of Expiration Exercise/ Number of voting % of votingfinancial date Conversion rights that may be rightsinstrument acquired if the Period/Date instrument is exercised/ converted. n/a n/a n/a n/a n/a Total (A+B) Number of voting rights % of voting rightsNot Reportable Not Reportable 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable Proxy Voting: 10. Name of the proxy holder: n/a 11. Number of voting rights proxy holder will cease to hold: n/a 12. Date on which proxy holder will cease to hold voting rights: n/a 13. Additional information n/a 14. Contact name: David Campbell, Finance Director 15. Contact telephone number: + 44 (0) 1223 896000 For further information, please contact: David Campbell, Finance DirectorALIZYME plc Tel No: + 44 (0) 1223 896000 Further information on Alizyme can be found on the Company's website: www.alizyme.com This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Barclays